Zobrazeno 1 - 10
of 119
pro vyhledávání: '"CHIH-CHIN LIU"'
Autor:
Philippe Merle, Masatoshi Kudo, Julien Edeline, Mohamed Bouattour, Ann-Lii Cheng, Stephen Lam Chan, Thomas Yau, Marcelo Garrido, Jennifer Knox, Bruno Daniele, Valeriy Breder, Ho Yeong Lim, Sadahisa Ogasawara, Stéphane Cattan, Yee Chao, Abby B. Siegel, Iván Martinez-Forero, Ziwen Wei, Chih-Chin Liu, Richard S. Finn
Publikováno v:
Liver Cancer (2023)
Introduction: KEYNOTE-240 showed a favorable benefit/risk profile for pembrolizumab versus placebo in patients with sorafenib-treated advanced hepatocellular carcinoma (HCC); however, prespecified statistical significance criteria for overall surviva
Externí odkaz:
https://doaj.org/article/cd768b0d783a455fbb086706dc35b886
Autor:
Chih-Chin Liu, Chang-Hua Chen, Chuan Yi Tang, Kuan-Hsueh Chen, Zhao-Feng Chen, Shih-Hao Chang, Chi-Ying Tsai, Ming-Li Liou
Publikováno v:
Journal of Microbiology, Immunology and Infection, Vol 51, Iss 2, Pp 278-285 (2018)
Backgroud/purpose: Aggregatibacter actinomycetemcomitans has emerged as one of the aetiological agents in periodontal disease. Although Type IV secretion systems (T4SSs) are widely distributed in many bacteria, the genetic features and distribution o
Externí odkaz:
https://doaj.org/article/b61bd4bfe0ba47348c4342aac8a4ed1c
Autor:
Meng-Jiun Lai, Chih-Chin Liu, Shinn-Jong Jiang, Po-Chi Soo, Meng-Hsuan Tu, Jen-Jyh Lee, Ying-Huei Chen, Kai-Chih Chang
Publikováno v:
Molecules, Vol 20, Iss 10, Pp 19277-19290 (2015)
The high incidence of Mycobacterium infection, notably multidrug-resistant M. tuberculosis infection, has become a significant public health concern worldwide. In this study, we isolate and analyze a mycobacteriophage, BTCU-1, and a foundational stud
Externí odkaz:
https://doaj.org/article/1a0d028863044b5cae534c9ba2bbbec3
Autor:
Colin Baigent, JonathanR. Emberson, Richard Haynes, William G. Herrington, Parminder Judge, Martin J. Landray, Kaitlin J. Mayne, Sarah Y.A. Ng, David Preiss, Alistair J. Roddick, Natalie Staplin, Doreen Zhu, Stefan D. Anker, Deepak L. Bhatt, Martina Brueckmann, Javed Butler, David Z.I. Cherney, Jennifer B. Green, Sibylle J. Hauske, Hiddo J.L. Heerspink, Silvio E. Inzucchi, Meg J. Jardine, Chih-Chin Liu, Kenneth W. Mahaffey, Finnian R. McCausland, Darren K. McGuire, John J.V. McMurray, Bruce Neal, Brendon L. Neuen, Milton Packer, Vlado Perkovic, Marc S. Sabatine, Scott D. Solomon, Muthiah Vaduganathan, Christoph Wanner, David C. Wheeler, Stephen D. Wiviott, Faiez Zannad
Publikováno v:
The Lancet. 400:1788-1801
Large trials have shown that sodium glucose co-transporter-2 (SGLT2) inhibitors reduce the risk of adverse kidney and cardiovascular outcomes in patients with heart failure or chronic kidney disease, or with type 2 diabetes and high risk of atheroscl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef5c3517816940eed83d96cf1419b14a
https://doi.org/10.1016/s0140-6736(22)02074-8
https://doi.org/10.1016/s0140-6736(22)02074-8
Autor:
David Z.I. Cherney, Samuel Dagogo-Jack, Francesco Cosentino, Richard E. Pratley, Robert Frederich, Mario Maldonado, Chih-Chin Liu, Christopher P. Cannon
Publikováno v:
Kidney International Reports. 7:1782-1792
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9eeacfbe21c597e4b938774f03398b77
https://doi.org/10.1016/j.ekir.2022.05.007
https://doi.org/10.1016/j.ekir.2022.05.007
Autor:
David Z.I. Cherney, Francesco Cosentino, Darren K. McGuire, Ahmed A. Kolkailah, Samuel Dagogo-Jack, Richard E. Pratley, Robert Frederich, Mario Maldonado, Chih-Chin Liu, Christopher P. Cannon
Publikováno v:
Kidney Int Rep
INTRODUCTION: In the eValuation of ERTugliflozin effIcacy and Safety CardioVascular outcomes (VERTIS CV) trial (NCT01986881), patients with type 2 diabetes mellitus (T2DM) and atherosclerotic cardiovascular disease (ASCVD) were randomized (1:1:1) to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40f80978bfa3059f466b2cb8836d8bc6
https://europepmc.org/articles/PMC10105061/
https://europepmc.org/articles/PMC10105061/
Autor:
Joseph M. Kim, Deepak L. Bhatt, Samuel Dagogo‐Jack, David Z. I. Cherney, Francesco Cosentino, Darren K. McGuire, Richard E. Pratley, Chih‐Chin Liu, Nilo B. Cater, Robert Frederich, James P. Mancuso, Christopher P. Cannon
Publikováno v:
Diabetes, obesitymetabolism.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::252871282c91088dac94ce361cb763ad
https://pubmed.ncbi.nlm.nih.gov/36594154
https://pubmed.ncbi.nlm.nih.gov/36594154
Autor:
A. Pong, Bernard Charbonnel, David Z.I. Cherney, Jie Liu, Christopher P. Cannon, Richard E. Pratley, Samuel Dagogo-Jack, Francesco Cosentino, Chih-Chin Liu, Darren K. McGuire, Mario Maldonado, Robert Frederich
Publikováno v:
Circulation. 143:602-605
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::101546ddfbd8a1bfa6d41b76c37772d5
https://doi.org/10.1161/circulationaha.120.051901
https://doi.org/10.1161/circulationaha.120.051901
Autor:
SAMUEL DAGOGO-JACK, CHRISTOPHER P. CANNON, DAVID CHERNEY, FRANCESCO COSENTINO, DARREN K. MCGUIRE, JIE LIU, CHIH-CHIN LIU, ROBERT FREDERICH, JAMES P. MANCUSO, RICHARD E. PRATLEY
Publikováno v:
Diabetes. 71
This analysis assessed the incidence and total events of hypoglycemia in VERTIS CV (NCT01986881) , the cardiovascular (CV) outcome trial for ertugliflozin (ERTU) in patients (pts) with type 2 diabetes and atherosclerotic CV disease. Hypoglycemia was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ae90f1a7b47a03a60f3e6066973837ae
https://doi.org/10.2337/db22-865-p
https://doi.org/10.2337/db22-865-p
Autor:
VIKAS S. SRIDHAR, FRANCESCO COSENTINO, SAMUEL DAGOGO-JACK, RICHARD E. PRATLEY, ROBERT FREDERICH, MARGARET N. ESSEX, MARIO MALDONADO, CHIH-CHIN LIU, JAMES P. MANCUSO, DAVID CHERNEY
Publikováno v:
Diabetes. 71
The effect of ertugliflozin (ERTU) on serum uric acid (SUA) and gout-related outcomes in VERTIS CV (NCT01986881) was investigated. Patients with T2D and ASCVD were randomized to ERTU 5 mg (n=2752) , 15 mg (n=2747) (doses pooled for analyses) , placeb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c967d6a50d58fd07a1e2e3caaec8e77
https://doi.org/10.2337/db22-859-p
https://doi.org/10.2337/db22-859-p